Dysglycemia associations with adipose tissue among HIV-infected patients after 2 years of antiretroviral therapy in Mwanza: a follow-up cross-sectional study

Table 1 Comparison of NUSTART recruitment characteristics of patients followed-up at 2–3 years post-ART initiation versus those not followed-up (due to loss to follow-up, lack of data or death)^a

	Followed-up at 2–3 years post ART (n = 273)	Lost to follow-up or died before 2–3 years-post ART (n = 431)		P-value^b
	Followed-up at 2–3 years post ART (n = 273)	Lost to follow-up (n = 145)	Died (n = 286)	P-value^b
Age at baseline, year	38.9 (9.7)	35.9 (9.7)	38.3 (9.9)	0.01^e
Female, n (%)	178 (65.2)	76 (52.4)	133 (45.6)	<0.0001
Marital status, n (%)^c
Married	122 (44.7)	48 (33.3)	114 (39.9)	0.16
Widow/widower	38 (13.9)	17 (11.8)	40 (14.0)
Divorced/separated	94 (34.4)	59 (41.0)	96 (33.5)
Single	19 (7.0)	19 (13.2)	34 (11.9)
Lives with partner	0 (0.0)	1 (0.7)	2 (0.7)
Occupation, n (%)^c
Salaried	6 (2.2)	8 (5.6)	10 (3.5)	0.16
Self-employed	237 (86.8)	119 (82.6)	251 (87.8)
Housewife	19 (7.0)	6 (4.1)	10 (3.5)
Student	2 (0.7)	3 (2.1)	1 (0.3)
Unemployed	9 (3.3)	8 (5.6)	14 (4.9)
Education level, n (%)^c
None	81 (29.6)	31 (21.5)	82 (28.7)	0.01
Primary	176 (64.5)	104 (72.2)	192 (67.1)
Secondary	16 (5.9)	5 (3.5)	11 (3.9)
University/Tertiary	0 (0)	4 (2.8)	1 (0.3)
Social economic status, n (%)
Lowest	58 (21.3)	19 (13.1)	64 (22.4)	0.10
Low	64 (23.4)	24 (16.6)	62 (21.7)
Middle	54 (19.8)	28 (19.3)	50 (17.5)
High	47 (17.2)	39 (26.9)	55 (19.2)
Highest	50 (18.3)	35 (24.1)	55 (19.2)
Fat mass index (kg/m²)^d	2.9 (0.8)	2.7 (0.8)	2.5 (0.8)	<0.0001^f
Fat-free mass index (kg/m²)^d	14.0 (0.9)	14.1 (0.8)	13.9 (1.0)	0.14
Body mass index (kg/m²)	16.7 (1.2)	16.7 (1.2)	16.2 (1.5)	0.0001^g
CD4 count (cells/μL)	127 (99.7)	116 (102.8)	113 (106.8)	0.29
Tuberculosis treatment, n (%)	63 (23.1)	49 (33.8)	48 (16.8)	<0.0001

^aData are mean ± SD unless specified as n (%)
^bcomparison done by oneway ANOVA test for continuous outcomes and chi-squared test for categorical outcomes
^c1 patient missing in the lost-to follow-up group
^d25 patients in the followed-up group, 16 in the lost to follow-up group, and 68 in the died group missing
^eBonferroni test showed differences between the followed-up group and the lost to follow-up group (P = 0.009) and the lost to follow-up group and the died group (P = 0.049)
^fBonferroni test showed differences between the followed-up group and the died group (P < 0.0001)
^gBonferroni test showed differences between the followed-up group and the died group (P < 0.0001) and the lost to follow-up group and the died group (P < 0.0001)